Last $56.63 USD
Change Today +1.12 / 2.02%
Volume 11.2M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 4:15 PM 10/23/14 All times are local (Market data is delayed by at least 15 minutes).

merck & co. inc. (MRK) Snapshot

Open
$56.26
Previous Close
$55.51
Day High
$57.07
Day Low
$56.19
52 Week High
09/8/14 - $61.33
52 Week Low
11/1/13 - $44.62
Market Cap
163.4B
Average Volume 10 Days
14.8M
EPS TTM
$3.58
Shares Outstanding
2.9B
EX-Date
09/11/14
P/E TM
15.8x
Dividend
$1.76
Dividend Yield
3.11%
Current Stock Chart for MERCK & CO. INC. (MRK)

merck & co. inc. (MRK) Details

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company’s Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company’s Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

77,300 Employees
Last Reported Date: 02/27/14
Founded in 1891

merck & co. inc. (MRK) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $1.5M
Executive Vice President and President of Mer...
Total Annual Compensation: $1.2M
Executive Vice President and President of Glo...
Total Annual Compensation: $957.3K
Compensation as of Fiscal Year 2013.

merck & co. inc. (MRK) Key Developments

Merck & Company and Sanofi Announce a License Application for Investigational Pediatric Hexavalent Vaccine

Merck & Company and Sanofi announced a license application for the company's investigational pediatric hexavalent vaccine to treat six diseases was accepted for review by the U.S. Food and Drug Administration. If approved, it would be the first pediatric vaccine to help protect against six diseases: diphtheria, tetanus, whooping cough, polio types 1, 2 and 3, disease cause by Haemophilus influenza type B and hepatitis B. In a phase III study, the drug, known as DTaP5-IPV-Hib-HepB1, was given to infants ages 2, 4 and 6 while other children received Sanofi Pentacel 2 and Merck's Recombivax HB treatments that are already licensed.

Merck Announces Final Results of Tender Offers for Eight Series of Notes

Merck & Co. Inc. announced the final results of the previously announced offers to purchase any and all of eight series outstanding notes. On Oct. 6, 2014, Merck commenced the Offers in accordance with the terms and conditions set in the Offer to Purchase, dated Oct. 6, 2014. The Offers expired at 5:00 p.m., New York City time, on Oct. 14, 2014. Payment for the Notes accepted pursuant to the Offers will be made on the expected settlement date Oct. 15, 2014. The applicable purchase price for each series of Notes will be paid together with accrued and unpaid interest from, and including, the last interest payment date for such series of Notes to, but excluding, the Settlement Date.

A Federal Judge Turns Back an Effort by Merck & Co. to Dismiss $100 Million Lawsuit Filed by Female Sales Representatives

A federal judge turned back an effort by lawyers for Merck & Co. to dismiss a $100 million lawsuit filed by female sales representatives who claim the drugmaker fosters a 'boys club' that rewards male 'breadwinners' with promotions and demotes women after they return from pregnancy leave. U.S. District Court Judge Joel Pisano did not rule on the merits of the class action lawsuit but said the women have raised issues that are 'plausible'. Merck said it will continue to defend itself against the allegations. The lawsuit was filed in May 2013 by five female Merck employees on behalf of others who may find themselves in a similar situation. They claim female sales representatives, particularly those who were pregnant, were paid less than male employees. It claims Merck's personnel decisions were rooted in stereotypes that view men as 'breadwinners' responsible for the sole support of their families while women should 'stay at home' with children. The lawsuit claims women who complained were repeatedly shot down by upper level managers. Among the plaintiffs is Kelli Smith, a senior sales representative for the company from June 2004 through December 2013. Smith claims she was paid less than male employees for the same job and demoted after she returned from pregnancy leave.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $56.63 USD +1.12

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $145.05 USD +6.10
Bayer AG €106.66 EUR +2.17
Gilead Sciences Inc $107.18 USD +1.09
Pfizer Inc $28.60 USD +0.30
Roche Holding AG SFr.279.40 CHF +1.10
View Industry Companies
 

Industry Analysis

MRK

Industry Average

Valuation MRK Industry Range
Price/Earnings 29.3x
Price/Sales 3.7x
Price/Book 3.3x
Price/Cash Flow 28.5x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit www.merck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.